☰

Amanda King - Publications

Affiliations: 
Neuro-Oncology National Cancer Institute, NIH, Bethesda, Bethesda, MD, United States 
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Adegbesan KA, Tomassoni Ardori F, Yanpallewar S, Bradley SP, Chudasama Y, Vera E, Briceno N, King AL, Tessarollo L, Gilbert MR, Guedes VA, Smart DK, Armstrong TS, Shuboni-Mulligan DD. The sex-dependent impact of PER2 polymorphism on sleep and activity in a novel mouse model of cranial-irradiation-induced hypersomnolence. Neuro-Oncology Advances. 5: vdad108. PMID 37781088 DOI: 10.1093/noajnl/vdad108  0.718
2023 King AL, Acquaye-Mallory AA, Vera E, Mendoza T, Reyes J, Stockdill ML, Gilbert MR, Armstrong TS. Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial. Bmc Cancer. 23: 262. PMID 36944930 DOI: 10.1186/s12885-023-10671-2  0.596
2023 King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye-Mallory AA, Adegbesan KA, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, et al. Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial. Journal of Neuro-Oncology. PMID 36884201 DOI: 10.1007/s11060-023-04271-0  0.587
2023 King AL, Acquaye AA, Mendoza T, Reyes J, Stockdill M, Gilbert MR, Armstrong TS, Vera E. Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial. Research Square. PMID 36865245 DOI: 10.21203/rs.3.rs-2521990/v1  0.567
2023 King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye AA, Adegbesan K, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, et al. Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial. Research Square. PMID 36789426 DOI: 10.21203/rs.3.rs-2522094/v1  0.568
2023 Roche KN, Cooper D, Armstrong TS, King AL. The link between psychological distress and survival in solid tumor patients: A systematic review. Cancer Medicine. PMID 36602400 DOI: 10.1002/cam4.5200  0.56
2022 Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, et al. Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering. Neuro-Oncology Advances. 5: vdac188. PMID 36820236 DOI: 10.1093/noajnl/vdac188  0.575
2022 King AL, Shuboni-Mulligan DD, Vera E, Crandon S, Acquaye AA, Boris L, Burton E, Choi A, Christ A, Grajkowska E, Jammula V, Leeper HE, Lollo N, Penas-Prado M, Reyes J, et al. Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients. Neuro-Oncology Practice. 9: 526-535. PMID 36388423 DOI: 10.1093/nop/npac049  0.746
2022 Vera E, Christ A, Grajkowska E, Briceno N, Choi A, Crandon SK, Wall K, Lindsley M, Leeper HE, Levine J, Reyes J, Acquaye AA, King AL, Jammula V, Roche K, et al. Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study. Eclinicalmedicine. 55: 101718. PMID 36386035 DOI: 10.1016/j.eclinm.2022.101718  0.531
2022 Shuboni-Mulligan DD, Young D, De La Cruz Minyety J, Briceno N, Celiku O, King AL, Munasinghe J, Wang H, Adegbesan KA, Gilbert MR, Smart DK, Armstrong TS. Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model. Scientific Reports. 12: 11131. PMID 35778467 DOI: 10.1038/s41598-022-15074-0  0.728
2022 Leeper HE, Tonorezos E, Mayer D, Bakitas M, Chang S, Cooley ME, Hervey-Jumper S, Miaskowski C, Sherwood P, Tsien C, Wallgren K, Willmarth N, Arons D, Acquaye A, King AL, et al. Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT). Neuro-Oncology Advances. 4: vdac029. PMID 35542753 DOI: 10.1093/noajnl/vdac029  0.45
2022 Rabin EE, Kim M, Mozny A, Cardoza K, Bell AC, Zhai L, Bommi P, Lauing KL, King AL, Armstrong TS, Walunas TL, Fang D, Roy I, Peipert JD, Sieg E, et al. A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer. Brain, Behavior, & Immunity - Health. 21: 100449. PMID 35368609 DOI: 10.1016/j.bbih.2022.100449  0.455
2021 Noll K, King AL, Dirven L, Armstrong TS, Taphoorn MJB, Wefel JS. Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors. Hematology/Oncology Clinics of North America. 36: 269-282. PMID 34711455 DOI: 10.1016/j.hoc.2021.08.011  0.553
2021 Rogers JL, Vera E, Acquaye A, Briceno N, Jammula V, King AL, Leeper H, Quezado MM, Gonzalez Alarcon J, Boris L, Burton E, Celiku O, Choi A, Christ A, Crandon S, et al. Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study. Neuro-Oncology Practice. 8: 460-474. PMID 34277024 DOI: 10.1093/nop/npab022  0.525
2020 Leggiero NM, Armstrong TS, Gilbert MR, King AL. Use of virtual reality for symptom management in solid-tumor patients with implications for primary brain tumor research: a systematic review. Neuro-Oncology Practice. 7: 477-489. PMID 33014388 DOI: 10.1093/Nop/Npaa012  0.597
2019 King A, Leggiero N, Acquaye A, Vera E, Crandon S, Gilbert M, Armstrong T. RBTT-03. USE OF VIRTUAL REALITY ENVIRONMENTS TO IMPROVE SELF-REPORTED DISTRESS, MOOD DISTURBANCE AND OVERALL SYMPTOM BURDEN USING CORRELATIVE STRESS BIOMARKERS IN PRIMARY BRAIN TUMOR (PBT) PATIENTS Neuro-Oncology. 21: vi219-vi219. DOI: 10.1093/Neuonc/Noz175.915  0.555
2019 Young D, Dee Smart D, King A, Gilbert M, Armstrong T, Shuboni-Mulligan D. RDNA-13. DOSE RESPONSE CURVE FOR RADIATION-INDUCED HYPERSOMNOLENCE (RIH) IN A MOUSE MODEL OF CRANIAL RADIATION: BEHAVIORAL ANALYSIS OF SLEEP AND ACTIVITY Neuro-Oncology. 21: vi209-vi209. DOI: 10.1093/Neuonc/Noz175.872  0.714
2019 King A, Shuboni-Mulligan D, Vera E, Crandon S, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Gartland C, Grajkowska E, Penas-Prado M, Reyes J, Leggiero N, et al. QOLP-36. THE IMPORTANCE OF SLEEP DISTURBANCE IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: CLINICAL CHARACTERISTICS & CO-OCCURRENCE WITH TUMOR-RELATED & PSYCHOLOGICAL SYMPTOMS Neuro-Oncology. 21: vi205-vi206. DOI: 10.1093/Neuonc/Noz175.856  0.75
2019 Leggiero N, Armstrong T, Vera E, Gilbert M, King A. QOLP-28. THE USE OF VIRTUAL REALITY FOR SYMPTOM MANAGEMENT: APPLICATION IN NEURO-ONCOLOGY Neuro-Oncology. 21: vi203-vi204. DOI: 10.1093/Neuonc/Noz175.848  0.592
Show low-probability matches.